发明名称 1-oxyalkyl-2-carboxy-7-nonsubstituted indole derivatives
摘要 Compounds of Formula I; wherein A1, B1, C1, D1, E1, F1 and L1 are as defined herein, which inhibit the activity of anti-apoptotic Mcl-1 protein, compositions containing the compounds, and methods of treating diseases involving overexpressed or unregulated Mdl-1 protein, such as leukemia and lymphoma, are disclosed.
申请公布号 US8853209(B2) 申请公布日期 2014.10.07
申请号 US201113088206 申请日期 2011.04.15
申请人 AbbVie Inc. 发明人 Song Xiaohong;Ding Hong;Elmore Steven W.;Bruncko Milan;Madar David J.;Souers Andrew J.;Park Cheol-Min;Tao Zhi-Fu;Wang Xilu;Kunzer Aaron R.
分类号 C07D209/42;C07D403/04 主分类号 C07D209/42
代理机构 Jones Day 代理人 Jones Day
主权项 1. A compound of Formula I,or a therapeutically acceptable salt thereof, wherein L1 is a bond; A1 is C(O)OH; B1 is 3-(1-naphthyloxy)propyl; C1 is R1; D1, E1 and F1 are each H; R1 is phenyl which is unfused or fused with benzene; wherein R1 is unsubstituted or substituted with one or two or three or four or five substituents independently selected from the group consisting of R10, OR10, OCH2R10, SR10, S(O)R10, SO2R10, C(O)R10, CO(O)R10, OC(O)R10, OC(O)OR10, NO2, NH2, NHR10, N(R10)2, CH2R10, C(O)NH2, C(O)NHR10, C(O)N(R10)2, NHC(O)R10, NR10C(O)R10, C(O)NHOH, C(O)NHOR10, C(O)NHSO2R10, C(O)NR10SO2R10, SO2NH2, SO2NHR10, SO2N(R10)2, CF3, CF2CF3, C(O)H, C(O)OH, C(N)NH2, C(N)NHR10, C(N)N(R10)2, ═NO-(alkylene)-C(O)CF3, CNOH, CNOCH3, OH, (O), N3, CF3, CF2CF3, OCF3, OCF2CF3, F, Cl, Br and I; R10 is R11, R12, R13 or R14; R11 is phenyl which is unfused or fused with benzene, heteroarene or R11A; R11A is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene; R12A is heteroaryl which is unfused or fused with benzene, heteroarene or R12A; R12A is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene; R13 is cycloalkyl, cycloalkenyl, heterocycloalkyl or heterocycloalkenyl, each of which is unfused or fused with benzene, heteroarene or R13A; R13A is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene; R14 is alkyl, alkenyl or alkynyl, each of which is unsubstituted or substituted with one, two, three, four or five substituents independently selected from the group consisting of R15, OR15, SR15, S(O)R15, SO2R15, NH2, NHR15, N(R15)2, C(O)R15, C(O)NH2, C(O)NHR15, C(O)N(R15)2, NHC(O)R15, NR15C(O)R15, NHSO2R15, NR15SO2R15, NHC(O)OR15, NR15C(O)OR15, SO2NH2, SO2NHR15, SO2N(R15)2, NHC(O)NH2, NHC(O)R15NHC(O)N(R15)2, NR15C(O)N(R15)2, OH, (O), C(O)OH, CN, CF3, OCF3, CF2CF3, F, Cl, Br and I; R15 is R16, R17, R18 or R19; R16 is phenyl which is unfused or fused with benzene, heteroarene or R15A; R15A is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene; R17 is heteroaryl which is unfused or fused with benzene, heteroarene or R16A; R16A is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene; R18 is cycloalkyl, cycloalkenyl, heterocycloalkyl or heterocycloalkenyl, each of which is unfused or fused with benzene, heteroarene or R18A; R18A is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene; R19 is alkyl, alkenyl or alkynyl, each of which is unsubstituted or substituted with R20; R20 is phenyl, heteroaryl, cycloalkyl, cycloalkenyl or heterocycloalkyl; wherein R11, R12, R13, R16, R17, and R18 are independently unsubstituted or substituted with one or two or three or four or five substituents independently selected from the group consisting of R21, OR21, OCH2R21, SR21, S(O)R21, SO2R21, C(O)R21, CO(O)R21, OC(O)R21, OC(O)OR21, NO2, NH2, NHR21, N(R21)2, CH2R21, C(O)NH2, C(O)NHR21, C(O)N(R21)2, NHC(O)R21, NR21C(O)R21, C(O)NHOH, C(O)NHOR21, C(O)NHSO2R21, C(O)NR21SO2R21, (alkylene)-C(O)CF3, CNOH, CNOCH3, OH, (O), N3, CF3, CF2CF3, OCF3, OCF2CF3, F, Cl, Br and I; and R21 is alkyl, alkenyl, alkynyl, phenyl, heteroaryl, cycloalkyl, cycloalkenyl or heterocycloalkyl.
地址 North Chicago IL US